2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Epygenix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants EPX-100, EPX-100-Matching Placebo, Moxifloxacin - Healthy Participants | Phase 1 | Recruiting | Epygenix | 88 | 2026-08-05 | 2026-10-16 |
| Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants EPX-100, Itraconazole, Phenytoin - Drug Drug Interaction | Phase 1 | Completed | Epygenix | 54 | 2025-01-15 | 2026-09-17 |
| Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. EPX-100 (Clemizole Hydrochloride), Placebos - Dravet Syndrome | Phase 1 | Completed | Epygenix | 24 | 2019-08-29 | 2024-09-19 |
Bupropion (1) · Itraconazole (1) · Midazolam (1) · Moxifloxacin (1) · Omeprazole (1) · Phenytoin (1) · clemizole (1)
United States (3)
Amit Ray, MD, MBA, FAES, FAAN (1) · Hahn-Jun Lee, Ph.D. (1) · Robert Faulkner, PhD (1)